Release of Patients Administered Radioactive Material, 36127-36128 [2019-15868]

Download as PDF Federal Register / Vol. 84, No. 144 / Friday, July 26, 2019 / Notices NATIONAL SCIENCE FOUNDATION Agency Information Collection Activities: Comment Request National Science Foundation. Submission for OMB review; comment request. AGENCY: jbell on DSK3GLQ082PROD with NOTICES ACTION: SUMMARY: The National Science Foundation (NSF) has submitted the following information collection requirement to OMB for review and clearance under the Paperwork Reduction Act of 1995. This is the second notice for public comment; the first was published in the Federal Register, and no comments were received. NSF is forwarding the proposed submission to the Office of Management and Budget (OMB) for clearance simultaneously with the publication of this second notice. The full submission may be found at: https:// www.reginfo.gov/public/do/PRAMain. DATES: Comments regarding this information collection are best assured of having their full effect if received by August 26, 2019. FOR FURTHER INFORMATION CONTACT: Office of Information and Regulatory Affairs of OMB, Attention: Desk Officer for National Science Foundation, 725 17th Street NW, Room 10235, Washington, DC 20503, and Suzanne H. Plimpton, Reports Clearance Officer, National Science Foundation, 2415 Eisenhower Avenue, Alexandria, VA 22314, or send email to splimpto@ nsf.gov. Individuals who use a telecommunications device for the deaf (TDD) may call the Federal Information Relay Service (FIRS) at 1–800–877– 8339, which is accessible 24 hours a day, 7 days a week, 365 days a year (including federal holidays). Copies of the submission may be obtained by calling 703–292–7556. SUPPLEMENTARY INFORMATION: NSF may not conduct or sponsor a collection of information unless the collection of information displays a currently valid OMB control number and the agency informs potential persons who are to respond to the collection of information that such persons are not required to respond to the collection of information unless it displays a currently valid OMB control number. Comments regarding (a) whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) the accuracy of the agency’s estimate of burden including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility and clarity of the VerDate Sep<11>2014 17:54 Jul 25, 2019 Jkt 247001 information to be collected; (d) ways to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology should be addressed to the points of contact in the FOR FURTHER INFORMATION CONTACT section. Title of Collection: Grantee Reporting Requirements for Partnerships for Research and Education in Materials (PREM). OMB Number: 3145–0232. Type of Request: Intent to seek approval to renew an information collection. Overview of this Information Collection: The Partnerships for Research and Education in Materials (PREM) aims to enhance diversity in materials research and education by stimulating the development of formal, long-term, collaborative research and education relationships between minority-serving colleges and universities and centers, institutes and facilities supported by the NSF Division of Materials Research (DMR). With this collaborative model PREMs build intellectual and physical infrastructure within and between disciplines, weaving together knowledge creation, knowledge integration, and knowledge transfer. PREMs conduct world-class research through partnerships of academic institutions, national laboratories, industrial organizations, and/or other public/private entities. New knowledge thus created is meaningfully linked to society, with an emphasis on enhancing diversity. PREMs enable and foster excellent education, integrate research and education, and create bonds between learning and inquiry so that discovery and creativity more fully support the learning process. PREMs capitalize on diversity through participation and collaboration in center activities and demonstrate leadership in the involvement of groups underrepresented in science and engineering. PREMs will be required to submit annual reports on progress and plans, which will be used as a basis for performance review and determining the level of continued funding. To support this review and the management of the award PREMs will be required to develop a set of management and performance indicators for submission annually to NSF via the Research Performance Project Reporting module in Research.gov. These indicators are both PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 36127 quantitative and descriptive and may include, for example, the characteristics of personnel and students; sources of financial support and in-kind support; expenditures by operational component; research activities; education activities; patents, licenses; publications; degrees granted to students involved in PREM activities; descriptions of significant advances and other outcomes of the PREM effort. Each PREM’s annual report will include the following categories of activities: (1) Research, (2) education (3) outreach, (4) partnerships, (5) diversity, (6) management, and (7) budget issues. For each of the categories the report will describe overall objectives for the year, problems the PREM has encountered in making progress towards goals, anticipated problems in the following year, and specific outputs and outcomes. PREMs are required to file a final report through the RPPR and external technical assistance contractor. Final reports contain similar information and metrics as annual reports but are retrospective. Use of the Information: NSF will use the information to continue funding of PREMs, and to evaluate the progress of the program. Estimate of Burden: 50 hours per PREM for 15 PREMs for a total of 750 hours. Respondents: Non-profit institutions. Estimated Number of Responses per Report: One from each of the fifteen PREMs. Dated: July 23, 2019. Suzanne H. Plimpton, Reports Clearance Officer, National Science Foundation. [FR Doc. 2019–15947 Filed 7–25–19; 8:45 am] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION [NRC–2019–0154] Release of Patients Administered Radioactive Material Nuclear Regulatory Commission. ACTION: Draft regulatory guide; request for comment. AGENCY: SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is issuing for public comment draft regulatory guide (DG), DG–8057, ‘‘Release of Patients Administered Radioactive Material.’’ This proposed guide, Revision 1, provides licensees with more detailed instructions to provide to patients E:\FR\FM\26JYN1.SGM 26JYN1 36128 Federal Register / Vol. 84, No. 144 / Friday, July 26, 2019 / Notices before and after they have been administered radioactive material than was in Revision 0. In addition, the guide includes a new section on ‘‘Death of a Patient Following Radiopharmaceutical or Implants Administrations,’’ as well as requirements for recordkeeping. Also, Table 3, ‘‘Dosages of Radiopharmaceuticals That Require Instructions and Records When Administered to Patients Who Are Breastfeeding an Infant or Child,’’ has been revised to provide information for the recommended duration of interruption of breastfeeding to ensure that the dose to an infant or child meets the NRC’s regulatory requirements. Submit comments by August 26, 2019. Comments received after this date will be considered if it is practical to do so, but the NRC is able to ensure consideration only for comments received on or before this date. Although a time limit is given, comments and suggestions in connection with the regulatory guides (RGs) currently being developed or improvements in all published RGs are encouraged at any time. DATES: You may submit comments by any of the following methods: • Federal rulemaking Website: Go to https://www.regulations.gov/ and search for Docket ID NRC–2019–0154. Address questions about docket IDs in Regulations.gov to Jennifer Borges; telephone: 301–287–9127; email: Jennifer.BorgesRoman@nrc.gov. For technical questions, contact the individuals listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: Office of Administration, Mail Stop: TWFN– 7A06, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001, ATTN: Program Management, Announcements and Editing Staff. For additional direction on accessing information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. ADDRESSES: jbell on DSK3GLQ082PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Vered Shaffer, telephone: 630–829– 9862, email: Vered.Shaffer@nrc.gov, and Harriet Karagiannis, telephone: 301– 415–2493, email: Harriet.Karagiannis@ nrc.gov. Both are staff members of the Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 17:54 Jul 25, 2019 Jkt 247001 I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2019– 0154 when contacting the NRC about the availability of information regarding this document. You may obtain publicly available information related to this document, by any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov/ and search for Docket ID NRC–2019–0154. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The DG– 8057 is available in ADAMS under Accession No. ML19108A463. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. B. Submitting Comments Please include Docket ID NRC–2019– 0154 in your comment submission. The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC posts all comment submissions at https:// www.regulations.gov/ as well as entering the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment submissions into ADAMS. II. Additional Information The NRC is issuing for public comment a DG in the NRC’s ‘‘Regulatory Guide’’ series. This series was developed to describe and make PO 00000 Frm 00080 Fmt 4703 Sfmt 9990 available to the public information regarding methods that are acceptable to the NRC staff for implementing specific parts of the NRC’s regulations, techniques that the staff uses in evaluating specific issues or postulated events, and data that the staff needs in its review of applications for permits and licenses. The DG, entitled, ‘‘Release of Patients Administered Radioactive Material,’’ is temporarily identified by its task number, DG–8057. The DG–8057 is proposed Revision 1 to RG 8.39 This revision of the guide (Revision 1) provides licensees with more detailed instructions to provide to patients before and after they have been administered radioactive material than was in Revision 0. In addition, the guide includes a new section on ‘‘Death of a Patient Following Radiopharmaceutical or Implants Administrations,’’ as well as additional guidance for requirements for recordkeeping. Also, Table 3, ‘‘Dosages of Radiopharmaceuticals That Require Instructions and Records When Administered to Patients Who Are Breastfeeding an Infant or Child,’’ has been revised to provide information for the recommended duration of interruption of breastfeeding to ensure that the dose to an infant or child meet the NRC regulatory requirements. III. Backfitting and Issue Finality As discussed in the Implementation section of DG–8057, the NRC does not intend or approve any imposition of the guidance in this draft regulatory guide. Backfitting and issue finality considerations do not apply to licensees or applicants when performing activities under part 35 of title 10 of the Code of Federal Regulations (CFR). Therefore, the NRC has determined that its backfitting and issue finality regulations would not apply to this draft regulatory guide, if ultimately issued as Revision 1 to RG 8.39, because the draft regulatory guide does not include any provisions within the scope of matters covered by the backfitting provisions in 10 CFR parts 50, 70, 72, or 76 or the issue finality provisions of 10 CFR part 52. Dated at Rockville, Maryland, this 22nd day of July 2019. For the Nuclear Regulatory Commission. Thomas H. Boyce, Chief, Regulatory Guidance and Generic Issues Branch, Division of Engineering, Office of Nuclear Regulatory Research. [FR Doc. 2019–15868 Filed 7–25–19; 8:45 am] BILLING CODE 7590–01–P E:\FR\FM\26JYN1.SGM 26JYN1

Agencies

[Federal Register Volume 84, Number 144 (Friday, July 26, 2019)]
[Notices]
[Pages 36127-36128]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15868]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2019-0154]


Release of Patients Administered Radioactive Material

AGENCY: Nuclear Regulatory Commission.

ACTION: Draft regulatory guide; request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is issuing for 
public comment draft regulatory guide (DG), DG-8057, ``Release of 
Patients Administered Radioactive Material.'' This proposed guide, 
Revision 1, provides licensees with more detailed instructions to 
provide to patients

[[Page 36128]]

before and after they have been administered radioactive material than 
was in Revision 0. In addition, the guide includes a new section on 
``Death of a Patient Following Radiopharmaceutical or Implants 
Administrations,'' as well as requirements for recordkeeping. Also, 
Table 3, ``Dosages of Radiopharmaceuticals That Require Instructions 
and Records When Administered to Patients Who Are Breastfeeding an 
Infant or Child,'' has been revised to provide information for the 
recommended duration of interruption of breastfeeding to ensure that 
the dose to an infant or child meets the NRC's regulatory requirements.

DATES: Submit comments by August 26, 2019. Comments received after this 
date will be considered if it is practical to do so, but the NRC is 
able to ensure consideration only for comments received on or before 
this date. Although a time limit is given, comments and suggestions in 
connection with the regulatory guides (RGs) currently being developed 
or improvements in all published RGs are encouraged at any time.

ADDRESSES: You may submit comments by any of the following methods:
     Federal rulemaking Website: Go to https://www.regulations.gov/ and search for Docket ID NRC-2019-0154. Address 
questions about docket IDs in Regulations.gov to Jennifer Borges; 
telephone: 301-287-9127; email: [email protected]. For 
technical questions, contact the individuals listed in the FOR FURTHER 
INFORMATION CONTACT section of this document.
     Mail comments to: Office of Administration, Mail Stop: 
TWFN-7A06, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001, ATTN: Program Management, Announcements and Editing Staff.
    For additional direction on accessing information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Vered Shaffer, telephone: 630-829-
9862, email: [email protected], and Harriet Karagiannis, telephone: 
301-415-2493, email: [email protected]. Both are staff 
members of the Office of Nuclear Regulatory Research, U.S. Nuclear 
Regulatory Commission, Washington, DC 20555-0001.

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2019-0154 when contacting the NRC 
about the availability of information regarding this document. You may 
obtain publicly available information related to this document, by any 
of the following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov/ and search for Docket ID NRC-2019-0154.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to [email protected]. The 
DG-8057 is available in ADAMS under Accession No. ML19108A463.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

B. Submitting Comments

    Please include Docket ID NRC-2019-0154 in your comment submission. 
The NRC cautions you not to include identifying or contact information 
that you do not want to be publicly disclosed in your comment 
submission. The NRC posts all comment submissions at https://www.regulations.gov/ as well as entering the comment submissions into 
ADAMS. The NRC does not routinely edit comment submissions to remove 
identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment submissions into ADAMS.

II. Additional Information

    The NRC is issuing for public comment a DG in the NRC's 
``Regulatory Guide'' series. This series was developed to describe and 
make available to the public information regarding methods that are 
acceptable to the NRC staff for implementing specific parts of the 
NRC's regulations, techniques that the staff uses in evaluating 
specific issues or postulated events, and data that the staff needs in 
its review of applications for permits and licenses.
    The DG, entitled, ``Release of Patients Administered Radioactive 
Material,'' is temporarily identified by its task number, DG-8057. The 
DG-8057 is proposed Revision 1 to RG 8.39
    This revision of the guide (Revision 1) provides licensees with 
more detailed instructions to provide to patients before and after they 
have been administered radioactive material than was in Revision 0. In 
addition, the guide includes a new section on ``Death of a Patient 
Following Radiopharmaceutical or Implants Administrations,'' as well as 
additional guidance for requirements for recordkeeping.
    Also, Table 3, ``Dosages of Radiopharmaceuticals That Require 
Instructions and Records When Administered to Patients Who Are 
Breastfeeding an Infant or Child,'' has been revised to provide 
information for the recommended duration of interruption of 
breastfeeding to ensure that the dose to an infant or child meet the 
NRC regulatory requirements.

III. Backfitting and Issue Finality

    As discussed in the Implementation section of DG-8057, the NRC does 
not intend or approve any imposition of the guidance in this draft 
regulatory guide. Backfitting and issue finality considerations do not 
apply to licensees or applicants when performing activities under part 
35 of title 10 of the Code of Federal Regulations (CFR). Therefore, the 
NRC has determined that its backfitting and issue finality regulations 
would not apply to this draft regulatory guide, if ultimately issued as 
Revision 1 to RG 8.39, because the draft regulatory guide does not 
include any provisions within the scope of matters covered by the 
backfitting provisions in 10 CFR parts 50, 70, 72, or 76 or the issue 
finality provisions of 10 CFR part 52.

    Dated at Rockville, Maryland, this 22nd day of July 2019.

    For the Nuclear Regulatory Commission.
Thomas H. Boyce,
Chief, Regulatory Guidance and Generic Issues Branch, Division of 
Engineering, Office of Nuclear Regulatory Research.
[FR Doc. 2019-15868 Filed 7-25-19; 8:45 am]
 BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.